Drugs for Optic Nerve Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Midazolam |
Approved, Illicit |
|
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Phase II Study of Fractionated CyberKnife Stereotactic Radiosurgery to Perioptic Tumors |
Completed |
NCT02225197 |
|
|
2 |
Observational Study on Multisession Radiosurgery for Optic Nerve Sheath Meningiomas |
Active, not recruiting |
NCT02594709 |
|
|
3 |
The Effects of Endotracheal Intubation or Laryngeal Mask Applications on Optic Nerve |
Not yet recruiting |
NCT05445271 |
|
|
|